400 related articles for article (PubMed ID: 22426762)
1. Fluorescence-guided resection of primary and recurrent malignant gliomas with 5-aminolevulinic acid. Preliminary results.
Tykocki T; Michalik R; Bonicki W; Nauman P
Neurol Neurochir Pol; 2012; 46(1):47-51. PubMed ID: 22426762
[TBL] [Abstract][Full Text] [Related]
2. Impact of the combination of 5-aminolevulinic acid-induced fluorescence with intraoperative magnetic resonance imaging-guided surgery for glioma.
Tsugu A; Ishizaka H; Mizokami Y; Osada T; Baba T; Yoshiyama M; Nishiyama J; Matsumae M
World Neurosurg; 2011; 76(1-2):120-7. PubMed ID: 21839963
[TBL] [Abstract][Full Text] [Related]
3. Counterbalancing risks and gains from extended resections in malignant glioma surgery: a supplemental analysis from the randomized 5-aminolevulinic acid glioma resection study. Clinical article.
Stummer W; Tonn JC; Mehdorn HM; Nestler U; Franz K; Goetz C; Bink A; Pichlmeier U;
J Neurosurg; 2011 Mar; 114(3):613-23. PubMed ID: 20397896
[TBL] [Abstract][Full Text] [Related]
4. Endoscopic-assisted visualization of 5-aminolevulinic acid-induced fluorescence in malignant glioma surgery: a technical note.
Rapp M; Kamp M; Steiger HJ; Sabel M
World Neurosurg; 2014; 82(1-2):e277-9. PubMed ID: 23871813
[TBL] [Abstract][Full Text] [Related]
5. Feasibility of fluorescence-guided resection of recurrent gliomas using five-aminolevulinic acid: retrospective analysis of surgical and neurological outcome in 58 patients.
Hickmann AK; Nadji-Ohl M; Hopf NJ
J Neurooncol; 2015 Mar; 122(1):151-60. PubMed ID: 25557106
[TBL] [Abstract][Full Text] [Related]
6. 5-Aminolevulinic acid fluorescence guided resection of malignant glioma: Hong Kong experience.
Chan DTM; Yi-Pin Sonia H; Poon WS
Asian J Surg; 2018 Sep; 41(5):467-472. PubMed ID: 28844780
[TBL] [Abstract][Full Text] [Related]
7. Association of 5-aminolevulinic acid fluorescence guided resection with photodynamic therapy in recurrent glioblastoma: a matched cohort study.
da Silva EB; Vasquez MWM; de Almeida Teixeira BC; Neto MC; Sprenger F; Filho JLN; Almeida-Lopes L; Ramina R
Acta Neurochir (Wien); 2024 May; 166(1):212. PubMed ID: 38739282
[TBL] [Abstract][Full Text] [Related]
8. Image guided surgery for the resection of brain tumours.
Barone DG; Lawrie TA; Hart MG
Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD009685. PubMed ID: 24474579
[TBL] [Abstract][Full Text] [Related]
9. Aminolevulinic acid (ALA)-protoporphyrin IX fluorescence guided tumour resection. Part 1: Clinical, radiological and pathological studies.
Colditz MJ; Jeffree RL
J Clin Neurosci; 2012 Nov; 19(11):1471-4. PubMed ID: 22959448
[TBL] [Abstract][Full Text] [Related]
10. Combining 5-Aminolevulinic Acid Fluorescence and Intraoperative Magnetic Resonance Imaging in Glioblastoma Surgery: A Histology-Based Evaluation.
Hauser SB; Kockro RA; Actor B; Sarnthein J; Bernays RL
Neurosurgery; 2016 Apr; 78(4):475-83. PubMed ID: 26407129
[TBL] [Abstract][Full Text] [Related]
11. Observational, retrospective study of the effectiveness of 5-aminolevulinic acid in malignant glioma surgery in Spain (The VISIONA study).
Díez Valle R; Slof J; Galván J; Arza C; Romariz C; Vidal C;
Neurologia; 2014 Apr; 29(3):131-8. PubMed ID: 23870657
[TBL] [Abstract][Full Text] [Related]
12. Coregistered fluorescence-enhanced tumor resection of malignant glioma: relationships between δ-aminolevulinic acid-induced protoporphyrin IX fluorescence, magnetic resonance imaging enhancement, and neuropathological parameters. Clinical article.
Roberts DW; Valdés PA; Harris BT; Fontaine KM; Hartov A; Fan X; Ji S; Lollis SS; Pogue BW; Leblond F; Tosteson TD; Wilson BC; Paulsen KD
J Neurosurg; 2011 Mar; 114(3):595-603. PubMed ID: 20380535
[TBL] [Abstract][Full Text] [Related]
13. Role of neurochemical navigation with 5-aminolevulinic acid during intraoperative MRI-guided resection of intracranial malignant gliomas.
Yamada S; Muragaki Y; Maruyama T; Komori T; Okada Y
Clin Neurol Neurosurg; 2015 Mar; 130():134-9. PubMed ID: 25615582
[TBL] [Abstract][Full Text] [Related]
14. Endoscopic-assisted 5-aminolevulinic acid imaging.
Schwartz TH
World Neurosurg; 2014; 82(1-2):e117-8. PubMed ID: 23920307
[No Abstract] [Full Text] [Related]
15. Fluorescence and image guided resection in high grade glioma.
Panciani PP; Fontanella M; Schatlo B; Garbossa D; Agnoletti A; Ducati A; Lanotte M
Clin Neurol Neurosurg; 2012 Jan; 114(1):37-41. PubMed ID: 21963142
[TBL] [Abstract][Full Text] [Related]
16. Supraorbital trans-eyebrow craniotomy and fluorescence-guided resection of fronto-basal high grade gliomas.
Prat-Acín R; Galeano-Senabre I; Pancucci G; Evangelista R; Ayuso-Sacido A; Botella C
Clin Neurol Neurosurg; 2013 Sep; 115(9):1586-90. PubMed ID: 23453153
[TBL] [Abstract][Full Text] [Related]
17. Aminolevulinic acid (ALA)-protoporphyrin IX fluorescence guided tumour resection. Part 2: theoretical, biochemical and practical aspects.
Colditz MJ; Leyen Kv; Jeffree RL
J Clin Neurosci; 2012 Dec; 19(12):1611-6. PubMed ID: 23059058
[TBL] [Abstract][Full Text] [Related]
18. Enhanced resection of primary high-grade gliomas using a combination of intraoperative magnetic resonance imaging and intraoperative fluorescence (5-aminolevulinic acid): A single-centre experience.
Sharma V; Kedia R; Narang KS; Jha AN
Neurol India; 2018; 66(3):747-752. PubMed ID: 29766937
[TBL] [Abstract][Full Text] [Related]
19. 5-Aminolevulinic Acid: Pitfalls of Fluorescence-guided Resection for Malignant Gliomas and Application for Malignant Glioma Therapy.
Yamamoto J; Kitagawa T; Miyaoka R; Suzuki K; Takamatsu S; Saito T; Nakano Y
J UOEH; 2020; 42(1):27-34. PubMed ID: 32213740
[TBL] [Abstract][Full Text] [Related]
20. A prospective Phase II clinical trial of 5-aminolevulinic acid to assess the correlation of intraoperative fluorescence intensity and degree of histologic cellularity during resection of high-grade gliomas.
Lau D; Hervey-Jumper SL; Chang S; Molinaro AM; McDermott MW; Phillips JJ; Berger MS
J Neurosurg; 2016 May; 124(5):1300-9. PubMed ID: 26544781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
